MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

MorphoSys AG (MOR) to Present at 42nd Annual J.P. Morgan Healthcare Conference

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 8, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PST in San Francisco, California. The company's Chief Financial Officer, Lucinda Crabtree, Ph.D., and Chief Research and Development Officer, Tim Demuth, M.D., Ph.D., will also be in attendance and available to address questions.

A live webcast of the presentation can be accessed on the Investors section of MorphoSys' website at https://www.morphosys.com/en/investors. An archived version of the webcast will be available on the company's website following the presentation.

About MorphoSys

At MorphoSys, we are driven by our mission: More life for people with cancer . As a global commercial-stage biopharmaceutical company, we develop and deliver innovative medicines, aspiring to redefine how cancer is treated. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts. To learn more, visit us at www.morphosys.com and follow us on Twitter at X and LinkedIn.

For more information, please contact:

Media Contacts: Thomas Biegi Senior Vice President, Corporate Affairs Tel: +49 (0)151 / 74612318 thomas.biegi@morphosys.com	Investor Contact: Dr. Julia Neugebauer Vice President, Global Investor Relations Tel: +49 (0)89 / 899 27 179 julia.neugebauer@morphosys.com
Eamonn Nolan Director, Corporate Communications & Investor Relations Tel: +1 617-548-9271 eamonn.nolan@morphosys.com

SOURCE: MorphoSys AG

View the original press release on accesswire.com

FAQ

When will Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys AG, present at the 42nd Annual J.P. Morgan Healthcare Conference?

Jean-Paul Kress, M.D. will present on Wednesday, January 10, 2024, at 3:00 p.m. PST in San Francisco, California.

Where can the live webcast of the presentation be accessed?

The live webcast can be accessed on the Investors section of MorphoSys' website at https://www.morphosys.com/en/investors.

Who else from MorphoSys AG will be in attendance at the conference?

The company's Chief Financial Officer, Lucinda Crabtree, Ph.D., and Chief Research and Development Officer, Tim Demuth, M.D., Ph.D., will also be in attendance and available to address questions.

When will the archived version of the webcast be available?

An archived version of the webcast will be available on the company's website following the presentation.